Eli Lilly Canada is recalling one lot of an injectable prescription drug used to treat blood glucose levels that have dropped too low, which may occur in people with diabetes who are treated with insulin.
The company is recalling the lot following a complaint that a vial from this lot of Glucagon — D239382A, expiry date May 10, 2022 — was found to be in liquid form instead of powder form.
Glucagon normally comes in a powder form, accompanied by a diluting solution, and should be used immediately after mixing, a statement from Health Canada released Saturday said.
“Vials from the affected lot may
This story was originally published on CBC News. To read the rest of this news worthy story, please visit https://www.cbc.ca/news/health/eli-lilly-canada-glucagon-recall-1.6190095?cmp=rss.